Roche Holding Ltd. (RHHBY) Lowered to “Neutral” at Citigroup Inc.

Citigroup Inc. cut shares of Roche Holding Ltd. (NASDAQ:RHHBY) from a buy rating to a neutral rating in a report released on Wednesday.

A number of other equities analysts have also weighed in on RHHBY. Deutsche Bank AG lowered shares of Roche Holding from a buy rating to a hold rating in a research report on Friday, July 7th. Morgan Stanley reissued an equal weight rating on shares of Roche Holding in a research report on Wednesday, July 26th. BNP Paribas reissued a neutral rating on shares of Roche Holding in a research report on Tuesday, June 20th. Cowen and Company reissued a buy rating and issued a $38.00 price objective on shares of Roche Holding in a research report on Tuesday, September 19th. Finally, Societe Generale lowered shares of Roche Holding from a buy rating to a hold rating in a research report on Friday, June 30th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of Hold and a consensus target price of $38.00.

Roche Holding (NASDAQ:RHHBY) traded down 1.919% during mid-day trading on Wednesday, reaching $30.415. 4,016,011 shares of the company’s stock were exchanged. Roche Holding has a 1-year low of $25.25 and a 1-year high of $36.82. The firm’s 50-day moving average is $31.69 and its 200 day moving average is $32.21. The stock has a market capitalization of $207.62 billion and a PE ratio of 20.471.

COPYRIGHT VIOLATION WARNING: “Roche Holding Ltd. (RHHBY) Lowered to “Neutral” at Citigroup Inc.” was first published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://transcriptdaily.com/2017/10/19/roche-holding-ltd-rhhby-lowered-to-neutral-at-citigroup-inc.html.

A number of hedge funds have recently modified their holdings of RHHBY. Parametric Portfolio Associates LLC increased its position in Roche Holding by 12.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,652,015 shares of the company’s stock worth $116,134,000 after purchasing an additional 400,190 shares during the last quarter. Capital Counsel LLC NY increased its position in Roche Holding by 30.5% during the second quarter. Capital Counsel LLC NY now owns 1,428,387 shares of the company’s stock worth $45,423,000 after purchasing an additional 334,008 shares during the last quarter. Bristol John W & Co. Inc. NY increased its position in Roche Holding by 13.1% during the second quarter. Bristol John W & Co. Inc. NY now owns 2,327,621 shares of the company’s stock worth $74,193,000 after purchasing an additional 269,099 shares during the last quarter. Icon Advisers Inc. Co. acquired a new position in Roche Holding during the second quarter worth approximately $4,617,000. Finally, Beach Investment Management LLC. acquired a new position in Roche Holding during the second quarter worth approximately $3,709,000.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (NASDAQ:RHHBY)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply